PROMOTING ACCESS TO AFFORDABLE PHARMACEUTICALS AND MEDICAL PRODUCTS
IFC works with generic pharmaceutical companies and global medical technology companies to bring the latest standard of care to emerging markets affordably.
Innovations in medical technology are contributing to earlier and better diagnostics for patients, even those living in remote places. Diagnostic solutions are available for a range of settings - home, doctor office, imaging center, ambulance, hospital bedside, central hospital location, or central lab.
Meanwhile, advances in pharmaceuticals are bringing therapies that are tailored to individuals, more effective, and with fewer side effects.
Fosun Pharma is one of China's leading drug companies and one of the largest suppliers of anti-malaria drugs through WHO and Red Cross. IFC's equity investment helps the company expand its business and increase availability of quality and affordable drugs in China and other developing countries.